Transcripts PharmaEssentia Corporation Deutsche Boerse AG

Stocks

Delayed Deutsche Boerse AG 03:34:57 2026-03-09 EDT			5-day change	1st Jan Change
15.50 ^EUR	-.--%		+11.00%	-

09-18	PharmaEssentia Gets Experts Board's Recommendation to Continue Phase 3 Myelofibrosis Drug Trial	MT
09-02	PharmaEssentia Receives FDA Approval For Ropeginterferon Alfa-2b-njft For Essential Thrombocythemia	CI

No results match your criteria

PharmaEssentia receives China NMPA approval for key Phase III clinical trial

March 27, 2025 at 05:48 am